SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001438533-22-000040
Filing Date
2022-08-18
Accepted
2022-08-18 16:06:46
Documents
5
Effectiveness Date
2022-08-18
Reference 429
333-258257

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_august2022.htm S-8 93465
2 EX-5.1 ex51_08182022.htm EX-5.1 9751
3 EX-23.2 ex232_08182022.htm EX-23.2 3249
4 EX-FILING FEES ex107_08182022.htm EX-FILING FEES 27640
5 GRAPHIC cooleygraphica01a.jpg GRAPHIC 24723
  Complete submission text file 0001438533-22-000040.txt   169546
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266957 | Film No.: 221177563
SIC: 2834 Pharmaceutical Preparations